Qi Yang

10PUBLICATIONS
48CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMolecular medicineMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 09, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.

Qi Yang, Bao Xue, Xianjie Qiu

|Jul 31, 2025
Cholesterol-rich lipid rafts mediate endocytosis as a common pathway for respiratory syncytial virus entry into different host cells.

Anqi Zhou, Bao Xue, Jiayi Zhong

|Jul 18, 2025
The crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies.

Zhuoqian Zhao, Qi Yang, Xiaoce Liu

|May 28, 2025
Construction of Minigenome Replicon of Nipah Virus and Investigation of Biological Activity.

Fan Wang, Ruyi Chen, Jiayi Zhong

|May 15, 2025
A novel, covalent broad-spectrum inhibitor targeting human coronavirus M<sup>pro</sup>.

Jing Sun, Deheng Sun, Qi Yang

|Jan 23, 2025
MA104 cell line is permissive for human bocavirus 1 infection.

Jielin Tang, Sijie Chen, Yijun Deng

Pageof 2

Frequent Collaborators

7 joint publications

Xinwen Chen

3 joint publications

Jielin Tang

3 joint publications

Jinsai Shang

3 joint publications

Haitao Yang